Joan‐Ramon Laporte

3.6k total citations
86 papers, 2.0k citations indexed

About

Joan‐Ramon Laporte is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Joan‐Ramon Laporte has authored 86 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 16 papers in Cardiology and Cardiovascular Medicine and 15 papers in Geriatrics and Gerontology. Recurrent topics in Joan‐Ramon Laporte's work include Pharmaceutical Practices and Patient Outcomes (15 papers), Drug-Induced Adverse Reactions (13 papers) and Pharmacovigilance and Adverse Drug Reactions (12 papers). Joan‐Ramon Laporte is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (15 papers), Drug-Induced Adverse Reactions (13 papers) and Pharmacovigilance and Adverse Drug Reactions (12 papers). Joan‐Ramon Laporte collaborates with scholars based in Spain, United Kingdom and Italy. Joan‐Ramon Laporte's co-authors include Xavier Vidal, Luisa Ibáñez, Lourdes Vendrell, Dolors Capellà, Roberto Leone, Josep Maria Castel, Albert Figueras, M. J. S. Langman, M. D. Rawlins and Bengt‐Erik Wiholm and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Joan‐Ramon Laporte

80 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan‐Ramon Laporte Spain 26 632 334 310 279 253 86 2.0k
Theresa Anderson United States 14 1.2k 1.9× 231 0.7× 207 0.7× 518 1.9× 219 0.9× 23 3.5k
Haleh Bagheri France 31 479 0.8× 289 0.9× 241 0.8× 373 1.3× 619 2.4× 176 3.0k
Xavier Carné Spain 23 318 0.5× 343 1.0× 251 0.8× 151 0.5× 148 0.6× 67 2.1k
Francisco J. de Abajo Spain 34 804 1.3× 491 1.5× 705 2.3× 246 0.9× 248 1.0× 130 3.8k
Ronald D. Mann United Kingdom 25 467 0.7× 162 0.5× 292 0.9× 381 1.4× 302 1.2× 77 2.1k
Gillian M. Shenfield Australia 28 349 0.6× 211 0.6× 279 0.9× 322 1.2× 109 0.4× 114 2.3k
François Montastruc France 29 387 0.6× 153 0.5× 253 0.8× 261 0.9× 406 1.6× 145 2.3k
Domenico Motola Italy 25 424 0.7× 176 0.5× 199 0.6× 198 0.7× 369 1.5× 87 1.7k
B.‐E. Wiholm Sweden 23 217 0.3× 220 0.7× 104 0.3× 233 0.8× 195 0.8× 35 1.7k
Robert L. Talbert United States 31 263 0.4× 407 1.2× 715 2.3× 226 0.8× 76 0.3× 117 2.7k

Countries citing papers authored by Joan‐Ramon Laporte

Since Specialization
Citations

This map shows the geographic impact of Joan‐Ramon Laporte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan‐Ramon Laporte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan‐Ramon Laporte more than expected).

Fields of papers citing papers by Joan‐Ramon Laporte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan‐Ramon Laporte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan‐Ramon Laporte. The network helps show where Joan‐Ramon Laporte may publish in the future.

Co-authorship network of co-authors of Joan‐Ramon Laporte

This figure shows the co-authorship network connecting the top 25 collaborators of Joan‐Ramon Laporte. A scholar is included among the top collaborators of Joan‐Ramon Laporte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan‐Ramon Laporte. Joan‐Ramon Laporte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sultana, Janet, Ugo Moretti, Antonio Addis, et al.. (2018). Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives. Drug Safety. 42(5). 683–687. 6 indexed citations
2.
Laporte, Joan‐Ramon & Eduardo Diogène. (2015). La pharmaco-épidémiologie : ombres et lumières. Bulletin de l Académie Nationale de Médecine. 199(2-3). 281–288.
3.
Sabaté, Mònica, Elena Ballarín, H. Petri, et al.. (2014). A compilation of research working groups on drug utilisation across Europe. BMC Research Notes. 7(1). 143–143. 9 indexed citations
4.
Ballarín, Elena, Mònica Sabaté, Joan‐Ramon Laporte, et al.. (2014). Sources of European drug consumption data at a country level. International Journal of Public Health. 59(5). 877–887. 13 indexed citations
5.
Théophile, Hélène, et al.. (2011). The Case-Population Study Design. Drug Safety. 34(10). 861–868. 26 indexed citations
6.
Pérez, E., Sergio Abanades, Xavier Vidal, et al.. (2010). Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomiting. British Journal of Clinical Pharmacology. 70(5). 656–663. 105 indexed citations
7.
Sabaté, Mònica, Luisa Ibáñez, E. Pérez, et al.. (2007). Risk of acute liver injury associated with the use of drugs: a multicentre population survey. Alimentary Pharmacology & Therapeutics. 25(12). 1401–1409. 48 indexed citations
8.
Vidal, Xavier, et al.. (2005). Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease. Kidney International. 67(6). 2393–2398. 28 indexed citations
9.
Ballarín, Elena, Luisa Ibáñez, José‐Ángel Hernández‐Rivas, Lluís Force, & Joan‐Ramon Laporte. (2005). Cyanamide-induced aplastic anemia. European Journal of Clinical Pharmacology. 61(5-6). 467–469.
10.
Kaufman, David W., Judith P. Kelly, Surapol Issaragrisil, et al.. (2005). Relative incidence of agranulocytosis and aplastic anemia. American Journal of Hematology. 81(1). 65–67. 34 indexed citations
11.
Ibáñez, Luisa, et al.. (2005). Upper gastrointestinal bleeding associated with antiplatelet drugs. Alimentary Pharmacology & Therapeutics. 23(2). 235–242. 101 indexed citations
12.
Vallano, Antonio, et al.. (2003). Impact of analgesic drug-use guidelines for the management of postoperative pain: a drug utilization study. International Journal of Clinical Pharmacology and Therapeutics. 41(4). 165–170. 2 indexed citations
13.
Castel, Josep Maria, et al.. (2003). Stimulating Adverse Drug Reaction Reporting. Drug Safety. 26(14). 1049–1055. 42 indexed citations
14.
Figueras, Albert, et al.. (2003). The Cuban experience in focusing pharmaceuticals policy to health population needs: initial results of the National Pharmacoepidemiology Network (1996–2001). Pharmacoepidemiology and Drug Safety. 12(5). 405–407. 4 indexed citations
15.
Sabaté, Mònica, et al.. (2002). Ús terapéutic del cannabis i els seus derivats. 85(4). 204–209. 1 indexed citations
16.
Lewis, Steff, M. J. S. Langman, Joan‐Ramon Laporte, et al.. (2002). Dose–response relationships between individual nonaspirin nonsteroidal anti‐inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta‐analysis based on individual patient data. British Journal of Clinical Pharmacology. 54(3). 320–326. 189 indexed citations
17.
Figueras, Albert, et al.. (2002). Health needs, drug registration and control in less developed countries—the Peruvian case. Pharmacoepidemiology and Drug Safety. 11(1). 63–64. 3 indexed citations
18.
Arnau, J.M., et al.. (1996). Utilidad de protocolos, formularios y guias terapéuticas para promover la prescripción racional de medicamentos.. 20(2). 41–47. 4 indexed citations
19.
Rodríguez, C., et al.. (1993). Therapeutic consultation: a necessary adjunct to independent drug information.. British Journal of Clinical Pharmacology. 35(1). 46–50. 8 indexed citations
20.
Capellà, Dolors, et al.. (1988). Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine.. BMJ. 297(6650). 722–723. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theresa Anderson Breakdown of academic impact, for papers by Haleh Bagheri Breakdown of academic impact, for papers by Xavier Carné Breakdown of academic impact, for papers by Francisco J. de Abajo Breakdown of academic impact, for papers by Ronald D. Mann Breakdown of academic impact, for papers by Gillian M. Shenfield Breakdown of academic impact, for papers by François Montastruc Breakdown of academic impact, for papers by Domenico Motola Breakdown of academic impact, for papers by B.‐E. Wiholm Breakdown of academic impact, for papers by Robert L. Talbert
Rankless by CCL
2026